What to know before buying weight loss medications online
The article discusses the increasing trend of purchasing weight loss medications online, particularly GLP-1 drugs, and the associated risks with unregulated sources.
Medications: How Well Does Each Weight Loss Drug Work?
The article discusses the recent advancements in weight loss medications available in Germany since 2023, emphasizing their effectiveness and potential to reduce related health conditions.
Novo Nordisk: Reducing drug prices for obesity and diabetes by 50% in the USA
Novo Nordisk has announced a 50% reduction in the prices of its obesity and diabetes medications in the USA, effective January 2027.
Losing too much weight with weight-loss pens worries doctors
Recent findings raise concerns among doctors regarding weight-loss medications that may cause excessive weight loss.
What if weight loss medications work too well?
There are emerging concerns regarding weight loss medications, which, while effective, may lead to unhealthy weight loss and eating disorders.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Patients discontinue weight loss medications too early because they are expensive, then they have a yo-yo effect, says doctor Fábryová
Doctor ĽubomÃra Fábryová discusses the challenges patients face when discontinuing expensive weight loss medications like Ozempic and Mounjaro too soon, leading to the common yo-yo effect in weight management.
Obesity medication against alcoholism? New study offers hope
A new study suggests that obesity medications like Mounjaro may effectively reduce alcohol consumption and relapse behaviors in rats and mice.
Rations for users of anti-obesity medications are reduced
Restaurants in the U.S. are reducing portion sizes in response to rising costs and increased use of anti-obesity medications.
New concerns about weight loss medications: What happens if they work too well?
Recent trials of a weight loss drug called retatrutide show significant weight loss, raising concerns among researchers about the potential for excessive weight loss and related side effects.
You achieved your weight loss goal with GLP-1 pens, and now?
The article discusses the rise of GLP-1 medications for weight loss, highlighting their effectiveness and increased accessibility with the introduction of oral formulations.
The hyped "wonder drug" may not necessarily lose a gram - A doctor explains what it's about
A new report highlights the ineffectiveness of certain obesity treatments, with insights from a leading doctor on the underlying reasons.
Anti-obesity medications 'reduce' sugar prices
Sugar prices have fallen to their lowest level in over five years, influenced by anti-obesity medications prompting consumers to shift towards protein consumption.
Medical advances will be for those who can afford them
The article discusses the recent advancements in obesity medications and the challenges of making them accessible to the broader population.
More people in the Czech Republic are entitled to weight loss medications than are currently taking them. What must be fulfilled?
In the Czech Republic, many more individuals qualify for weight loss medications than are actually utilizing them, raising questions about access and awareness.
Chamber accelerates processing of project that provides for patent breaking of weight loss pen
The Brazilian Chamber of Deputies has expedited the processing of a bill allowing the breaking of patents for medications based on tirzepatide, used for treating type 2 diabetes and obesity.
Cases of pancreatitis after using weight-loss pens are rare, experts say
Experts state that cases of pancreatitis linked to GLP-1 agonists used for diabetes and obesity are uncommon and should not cause alarm.
Have you achieved your weight loss goal with slimming pens; and now?
Medicines like GLP-1 have revolutionized obesity treatment, significantly impacting attitudes towards weight loss in the U.S.
About 125 children on weight control medications and 500 with fatty liver
Approximately 350 children are receiving treatment for obesity at the Children's Hospital in Reykjavik, with around 120 to 130 on weight control medications, and it is estimated that about 500 children in Iceland have fatty liver disease.
Polish diabetes and weight loss drug manufacturer Celon will employ 50 people in a new factory near Žilina
Polish pharmaceutical company Celon Pharma is set to establish a new factory in Žilina, creating 50 jobs and addressing the growing demand for diabetes and obesity medications.
More than 1 in 4 adults could benefit from new anti-obesity drugs
A study suggests implementing strategic programs for GLP-1 medications to address the global obesity crisis, while also warning about the rebound effect of drugs like Ozempic.
Obesity medications: what pharmacists and patients should pay attention to
The article discusses important considerations for pharmacists and patients regarding obesity medications, including their usage and potential side effects.
The cessation of obesity medications leads to weight regain and health risks within two years
A recent study reveals that the health benefits of weight-loss medications diminish quickly after discontinuation, with patients typically regaining weight and associated health risks within less than two years.
The trap of 'miracle' weight loss medications: the rebound effect is faster than with conventional diets
A study of 37 investigations reveals that the rebound weight gain from GLP-1 agonists happens in less than two years, highlighting the hidden downsides of these popular obesity therapies.
Professor Tim Spector issues dire health warning over skinny jabs
Nutrition expert Professor Tim Spector warns that focusing solely on weight loss through GLP-1 medications will not effectively address Britain's obesity crisis.
Will new obesity drugs also help fight aging?
New obesity drugs, GLP-1 analogs, show potential in slowing the aging of organs in both mice and HIV patients, with possible applications beyond diabetes and obesity.